# Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells

> **NCT01041287** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 96 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Metoprolol succinate

## Key facts

- **NCT ID:** NCT01041287
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041287, "Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01041287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*